Aardvark Therapeutics (AARD) Stock Insights

AARD price $1.45 +0.15 +11.54%

Ticker
AARD
Price
$1.45
Change
+0.15 +11.54%
Market cap ?
$31.73M
P/E ?
-0.43
Forward P/E ?
1.68
Dividend yield ?
0.00%
Beta ?
3.81
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
59
Quality
52
Growth
100

Stocklytics score rationale: value 59, quality 52, growth 100.

Financials

2022202320242025
0000

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an…

Fair value

AARD fair value $9.38. Price $1.45. Price is 85% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare AARD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.72——
2026-08-11-0.66-0.87——
2026-05-07-0.99-0.88——
2026-03-23-0.81-0.83——
2025-11-13-0.75-0.80——
2025-08-13-0.66-0.60——
2025-05-14-0.71-0.67——
2025-03-31-0.43-0.41——
2024-09-30-0.32———
2024-06-30-2.13———
2024-03-31-0.17———
2023-12-31-0.21———
2023-09-30-0.22———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-07Zhang ZhongweiBuy127.06K$4.96630.22K
2026-10-07Zhang ZhongweiOther0——
2026-09-11Sun NelsonSell62.00K$5.18321.18K
2026-09-10Sun NelsonSell14.75K$5.0073.78K
2026-08-14Chi JeffreyBuy44.96K$6.54294.06K
2026-08-14Graf Susan EBuy44.96K$6.54294.06K
2026-08-14Baynes Roy D.Buy44.96K$6.54294.06K
2026-08-14Tong Victor Edward JrBuy44.96K$6.54294.06K
2026-02-09Sun NelsonSell70.55K$13.48951.00K
2026-02-09Jaiman ManasiSell70.55K$13.48951.00K
2026-02-09Lee Tien-LiSell203.85K$13.482.75M
2025-12-11Sun NelsonBuy3.00K$14.4043.20K
2025-12-11Lee Tien-LiBuy7.00K$14.48101.39K
2025-10-15Lee Tien-LiBuy1.23K$4.245.21K
2025-10-15Lee Tien-LiSell1.23K$4.245.21K
2025-10-15Jones BryanSell1.25K$4.245.30K
2025-10-15Jones BryanBuy1.25K$4.245.30K
2025-09-15Lee Tien-LiBuy3.50K$9.9434.80K
2025-09-15Lee Tien-LiBuy6.50K$9.5161.82K
2025-09-12Lee Tien-LiBuy5.00K$8.5042.52K
2025-09-11Lee Tien-LiBuy6.00K$7.8246.93K
2025-09-10Lee Tien-LiBuy9.00K$7.9171.21K
2025-09-09Sun NelsonBuy6.00K$8.0748.44K
2025-08-28Lee Tien-LiBuy17.21K$4.2472.97K
2025-08-28Lee Tien-LiSell17.21K$4.2472.97K
2025-06-11Lee Tien-LiBuy549.53K$11.296.20M
2025-06-11Chi JeffreyBuy61.02K$11.29688.88K
2025-06-11Jaiman ManasiBuy127.00K$11.291.43M
2025-06-11Baynes Roy D.Buy30.51K$11.29344.44K
2025-06-11Tong Victor Edward JrBuy61.02K$11.29688.88K
2025-06-11Sun NelsonBuy209.83K$11.292.37M
2025-06-11Jones BryanBuy122.03K$11.291.38M
2025-06-11Graf Susan EBuy30.51K$11.29344.44K
2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P.Buy625.00K$16.0010.00M
2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P.Buy2.33M——
2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P.Buy625.00K$16.0010.00M
2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P.Buy333.41K——
2025-02-14Decheng Capital Global Life Sciences Fund IV, L.P.Sell2.83M——
2025-02-14Chi JeffreyBuy133.36K——
2025-02-14Chi JeffreySell1.13M——
2025-02-14Vickers Venture Fund VI Pte LtdBuy413.49K——
2025-02-14Vickers Venture Fund VI Pte LtdBuy1.64M——
2025-02-14Vickers Venture Fund VI Pte LtdSell3.50M——
2025-02-14Vickers Venture Fund VI Pte LtdSell13.88M——
2025-02-14Lee Tien-LiBuy16.54K$16.00264.67K
2025-02-14Lee Tien-LiBuy41.30K——
2025-02-14Lee Tien-LiSell350.00K——
2025-02-14Sun NelsonBuy10.00K$16.00160.00K
2025-02-14Sun NelsonBuy7.00K——
2025-02-14Sun NelsonSell59.33K——
2025-02-14Cormorant Asset Management, LPBuy187.50K$16.003.00M
2025-02-14Cormorant Asset Management, LPBuy800.19K——
2025-02-14Cormorant Asset Management, LPSell6.78M——
2025-02-12Decheng Capital Global Life Sciences Fund IV, L.P.Other333.41K——
2025-02-12Tong Victor Edward JrOther0——
2025-02-12Jones BryanOther35.40K$3.05107.98K
2025-02-12Jones BryanOther5.90K$1.287.55K
2025-02-12Jones BryanOther35.40K$3.06108.33K
2025-02-12Jones BryanOther41.30K$4.24175.12K
2025-02-12Sun NelsonOther0——
2025-02-12Sun NelsonOther7.00K——
2025-02-12Sun NelsonOther23.72K$4.24100.57K
2025-02-12Baynes Roy D.Other29.50K$7.04207.69K
2025-02-12Graf Susan EOther29.50K$7.04207.69K
2025-02-12Vickers Venture Fund VI Pte LtdOther1.64M——
2025-02-12Vickers Venture Fund VI Pte LtdOther413.49K——
2025-02-12Jaiman ManasiOther177.01K$4.24750.53K
2025-02-12Chi JeffreyOther133.36K——
2025-02-12Lee Tien-LiOther0——
2025-02-12Lee Tien-LiOther0——
2025-02-12Lee Tien-LiOther41.30K——
2025-02-12Lee Tien-LiOther59.00K$4.24250.18K
2025-02-12Cormorant Asset Management, LPOther6.78M——
2007-08-17Creamer James W IIIBuy500$1.90950
2007-03-06Zimlich Joseph CBuy5.00K$2.7513.75K
2006-12-06Creamer James W IIIBuy50.00K$1.3065.00K
2006-12-06Zimlich Joseph CBuy56.55K$1.3073.52K
2006-12-06Zimlich Joseph CBuy56.55K$1.3073.52K
2006-12-06Creamer James W IIIBuy50.00K$1.3065.00K
2006-11-08Creamer James W IIIBuy100.00K$1.65165.00K
2006-11-08Creamer James W IIIBuy100.00K$1.65165.00K
2006-10-26Zimlich Joseph CBuy17.00K$3.0051.00K
2006-10-26Zimlich Joseph CSell68.00K——
2006-05-12Creamer James W IIIBuy300$3.05915
2006-05-12Creamer James W IIIBuy300$3.05915
2006-05-03Creamer James W IIIOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 75, holders -6 vs prior quarter. Ownership 43.18%.

HolderSharesChangeChange %Value
DECHENG CAPITAL LLC3.92M00.00%22.56M
CITADEL ADVISORS LLC1.28M1.23M+2325.64%7.39M
LAURION CAPITAL MANAGEMENT LP1.03M00.00%5.96M
VANGUARD CAPITAL MANAGEMENT LLC562.88K8.78K+1.58%3.24M
AQR CAPITAL MANAGEMENT LLC480.25K345.75K+257.08%2.77M
ECOR1 CAPITAL, LLC396.19K396.19KNew2.28M
ADAGE CAPITAL PARTNERS GP, L.L.C.300.00K00.00%1.73M
BLACKROCK, INC.187.04K-605.53K-76.40%1.08M
GEODE CAPITAL MANAGEMENT, LLC149.84K-159.60K-51.58%863.53K
CANTOR FITZGERALD, L. P.116.58K49.90K+74.83%671.51K
TWO SIGMA INVESTMENTS, LP108.38K-54.98K-33.66%624.25K
RAYMOND JAMES FINANCIAL INC79.28K68.39K+628.04%456.68K
VANGUARD FIDUCIARY TRUST CO75.17K-8.04K-9.66%432.99K
WOODLINE PARTNERS LP72.43K00.00%417.19K
MILLENNIUM MANAGEMENT LLC69.95K-28.39K-28.87%402.90K
STATE STREET CORP59.27K-140.05K-70.26%341.41K
CITADEL ADVISORS LLC59.10K6.20K+11.72%340.42K
J. GOLDMAN & CO LP40.50K40.50KNew233.28K
IEQ CAPITAL, LLC38.38K21.90K+132.83%221.08K
UBS GROUP AG35.64K-122.25K-77.43%205.28K
MORGAN STANLEY30.18K12.62K+71.83%173.82K
NORTHERN TRUST CORP28.08K-60.52K-68.31%161.74K
CITIGROUP INC26.30K-19.97K-43.16%151.48K
CRESSET ASSET MANAGEMENT, LLC24.03K-19.23K-44.44%138.43K
SUSQUEHANNA INTERNATIONAL GROUP, LLP24.02K24.02KNew138.38K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Aardvark Therapeutics (AARD) Stock Insights

AARD$1.45+0.15 +11.54%

$31.73M

Market Cap

-0.43

P/E

1.68

Forward P/E

70

Score

Price History